Test Background Phenobarbitone is a general central nervous system suppressant that has proven effective in the control of generalised and partial seizures. It is frequently co-administered with phenytoin for control of complex seizure disorders, and with valproic acid for complex partial seizures.
Clinical Indications Therapeutic drug monitoring Assessing compliance or toxicity (symptoms of overdosage include: ataxia, nystagmus, fatigue or attention loss, progressing to respiratory arrest when pulmonary support is not supplied manually)
Reference Range 10-40 mg/L
Sample Required SST (gold top)
Sample Volume 0.5 mL
Turnaround Time 1 day